Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Amortization of Goodwill (2017 - 2018)

Altimmune (ALT) has disclosed Amortization of Goodwill for 2 consecutive years, with $490676.0 as the latest value for Q1 2018.

  • Quarterly Amortization of Goodwill changed N/A to $490676.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Sep 2018, changed N/A year-over-year, with the annual reading at $35.9 million for FY2017, N/A changed from the prior year.
  • Amortization of Goodwill for Q1 2018 was $490676.0 at Altimmune, down from $9.3 million in the prior quarter.
  • The five-year high for Amortization of Goodwill was $26.6 million in Q3 2017, with the low at $490676.0 in Q1 2018.